Atossa Therapeutics, Inc. (ATOS)

4.86 -0.02 (-0.41%) USD  |  NASDAQ  |  Apr 08, 10:42
More

Atossa Therapeutics Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for ATOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. --
Abeona Therapeutics, Inc. Upgrade
Cell Source, Inc. --
Kiora Pharmaceuticals, Inc. Upgrade